/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | ISCOInternational Stem C | NVDANVIDIA CORP | TSLATesla, Inc. | AAPLApple Inc. | PLTRPalantir Technologie |
|---|---|---|---|---|---|
| Last close | no stored close | $202.06close 2026-11-02 | $403.82close 2026-11-02 | $338.32close 2026-11-02 | $178.34close 2026-11-02 |
| Change % | no stored close | -1.26%close 2026-11-02 | +1.00%close 2026-11-02 | -1.83%close 2026-11-02 | -3.13%close 2026-11-02 |
| Market cap |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| no stored close |
| $4.87Tclose 2026-11-02 |
| $1.60Tclose 2026-11-02 |
| $4.92Tclose 2026-11-02 |
| $429.6Bclose 2026-11-02 |
| P/ENot comparable: periods differ | no stored close | 41.2FY to 2026-01-25 | 373.9FY to 2025-12-31 | 37.7FY to 2026-09-26 | 283.1FY to 2025-12-31 |
| Revenue | $9M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax As ofFY ending 2025-12-31 Filing10-K · 0001193125-26-131723 · filed 2026-03-30 Open the filing on EDGAR →Open the XBRL payload →CiteInternational Stem Cell CORP (ISCO), us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax: 9,100,000 USD, fiscal year ended 2025-12-31. Form 10-K, accession 0001193125-26-131723, filed 2026-03-30. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001355790/us-gaap/RevenueFromContractWithCustomerExcludingAssessedTax.json | $215.9B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2026-01-25 Filing10-K · 0001045810-26-000021 · filed 2026-02-25 Open the filing on EDGAR →Open the XBRL payload →CiteNVIDIA CORP (NVDA), us-gaap:Revenues: 215,938,000,000 USD, fiscal year ended 2026-01-25. Form 10-K, accession 0001045810-26-000021, filed 2026-02-25. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001045810/us-gaap/Revenues.json | $94.8B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2025-12-31 Filing10-K · 0001628280-26-003952 · filed 2026-01-29 Open the filing on EDGAR →Open the XBRL payload →CiteTesla, Inc. (TSLA), us-gaap:Revenues: 94,827,000,000 USD, fiscal year ended 2025-12-31. Form 10-K, accession 0001628280-26-003952, filed 2026-01-29. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001318605/us-gaap/Revenues.json | $478.8B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax As ofFY ending 2026-09-26 Filing10-K · 0000320193-26-000026 · filed 2026-11-03 Open the filing on EDGAR →Open the XBRL payload →CiteApple Inc. (AAPL), us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax: 478,834,000,000 USD, fiscal year ended 2026-09-26. Form 10-K, accession 0000320193-26-000026, filed 2026-11-03. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000320193/us-gaap/RevenueFromContractWithCustomerExcludingAssessedTax.json | $4.5B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax As ofFY ending 2025-12-31 Filing10-K · 0001321655-26-000011 · filed 2026-02-17 Open the filing on EDGAR →Open the XBRL payload →CitePalantir Technologies Inc. (PLTR), us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax: 4,475,446,000 USD, fiscal year ended 2025-12-31. Form 10-K, accession 0001321655-26-000011, filed 2026-02-17. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001321655/us-gaap/RevenueFromContractWithCustomerExcludingAssessedTax.json |
| Rev growth (YoY)Not comparable: periods differ | 0.2%FY to 2025-12-31 | 65.5%FY to 2026-01-25 | -2.9%FY to 2025-12-31 | 15.1%FY to 2026-09-26 | 56.2%FY to 2025-12-31 |
| Net income | $-418000⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 FilingDEF 14A · 0001193125-26-191906 · filed 2026-04-29 Open the filing on EDGAR →Open the XBRL payload →CiteInternational Stem Cell CORP (ISCO), us-gaap:NetIncomeLoss: -418,000 USD, fiscal year ended 2025-12-31. Form DEF 14A, accession 0001193125-26-191906, filed 2026-04-29. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001355790/us-gaap/NetIncomeLoss.json | $120.1B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2026-01-25 FilingDEF 14A · 0001045810-26-000036 · filed 2026-05-12 Open the filing on EDGAR →Open the XBRL payload →CiteNVIDIA CORP (NVDA), us-gaap:NetIncomeLoss: 120,067,000,000 USD, fiscal year ended 2026-01-25. Form DEF 14A, accession 0001045810-26-000036, filed 2026-05-12. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001045810/us-gaap/NetIncomeLoss.json | $3.9B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 FilingDEF 14A · 0001104659-26-116700 · filed 2026-10-19 Open the filing on EDGAR →Open the XBRL payload →CiteTesla, Inc. (TSLA), us-gaap:NetIncomeLoss: 3,855,000,000 USD, fiscal year ended 2025-12-31. Form DEF 14A, accession 0001104659-26-116700, filed 2026-10-19. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001318605/us-gaap/NetIncomeLoss.json | $132.2B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2026-09-26 Filing10-K · 0000320193-26-000026 · filed 2026-11-03 Open the filing on EDGAR →Open the XBRL payload →CiteApple Inc. (AAPL), us-gaap:NetIncomeLoss: 132,175,000,000 USD, fiscal year ended 2026-09-26. Form 10-K, accession 0000320193-26-000026, filed 2026-11-03. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000320193/us-gaap/NetIncomeLoss.json | $1.6B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 FilingDEF 14A · 0001321655-26-000019 · filed 2026-04-24 Open the filing on EDGAR →Open the XBRL payload →CitePalantir Technologies Inc. (PLTR), us-gaap:NetIncomeLoss: 1,625,033,000 USD, fiscal year ended 2025-12-31. Form DEF 14A, accession 0001321655-26-000019, filed 2026-04-24. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001321655/us-gaap/NetIncomeLoss.json |
| Net marginNot comparable: periods differ | -4.6%FY to 2025-12-31 | 55.6%FY to 2026-01-25 | 4.1%FY to 2025-12-31 | 27.6%FY to 2026-09-26 | 36.3%FY to 2025-12-31 |
| EPS (diluted) | $-0.05⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001193125-26-131723 · filed 2026-03-30 Open the filing on EDGAR →Open the XBRL payload →CiteInternational Stem Cell CORP (ISCO), us-gaap:EarningsPerShareDiluted: -0.05 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001193125-26-131723, filed 2026-03-30. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001355790/us-gaap/EarningsPerShareDiluted.json | $4.90⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2026-01-25 Filing10-K · 0001045810-26-000021 · filed 2026-02-25 Open the filing on EDGAR →Open the XBRL payload →CiteNVIDIA CORP (NVDA), us-gaap:EarningsPerShareDiluted: 4.90 USD per share, fiscal year ended 2026-01-25. Form 10-K, accession 0001045810-26-000021, filed 2026-02-25. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001045810/us-gaap/EarningsPerShareDiluted.json | $1.08⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001628280-26-003952 · filed 2026-01-29 Open the filing on EDGAR →Open the XBRL payload →CiteTesla, Inc. (TSLA), us-gaap:EarningsPerShareDiluted: 1.08 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001628280-26-003952, filed 2026-01-29. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001318605/us-gaap/EarningsPerShareDiluted.json | $8.98⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2026-09-26 Filing10-K · 0000320193-26-000026 · filed 2026-11-03 Open the filing on EDGAR →Open the XBRL payload →CiteApple Inc. (AAPL), us-gaap:EarningsPerShareDiluted: 8.98 USD per share, fiscal year ended 2026-09-26. Form 10-K, accession 0000320193-26-000026, filed 2026-11-03. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000320193/us-gaap/EarningsPerShareDiluted.json | $0.63⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001321655-26-000011 · filed 2026-02-17 Open the filing on EDGAR →Open the XBRL payload →CitePalantir Technologies Inc. (PLTR), us-gaap:EarningsPerShareDiluted: 0.63 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001321655-26-000011, filed 2026-02-17. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001321655/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 4FY to 2025-12-31 | 4FY to 2026-01-25 | 5FY to 2025-12-31 | 9FY to 2026-09-26 | 7FY to 2025-12-31 |
| Altman Z-ScoreUNVALIDATED | inputs not filed | 63.68FY to 2026-01-25 | 18.94FY to 2025-12-31 | 12.62FY to 2026-09-26 | 183.96FY to 2025-12-31 |
| Beneish M-ScoreUNVALIDATED | inputs not filed | -1.15FY to 2026-01-25 | inputs not filed | -2.52FY to 2026-09-26 | inputs not filed |
| Next earnings | rep. 04-01 | 11-13 → 11-23 | 01-22 → 02-01 | 01-23 → 02-02 | 01-27 → 02-06 |